Streptavidin Janelia Fluor® 549

(HB18064)
Technical documents: SDS Datasheet

Product overview

Name Streptavidin Janelia Fluor® 549
Biological description

Streptavidin Janelia Fluor® 549 is a biotin binding protein conjugated with the fluorescent dye Janelia Fluor® 549 and can be used to detect biotin labelled molecules such as nucleic acids, antibodies, and other proteins. Biotinylated antibodies are bound with extremely high affinity by Streptavidin Janelia Fluor® 549 enabling immunofluorescent detection in IHC, ICC, flow cytometry and Western blot. Janelia Fluor® 549 and the other members of the Janelia Fluor® family are bright and highly photostable fluorophores particularly suited for super resolution imaging such as dSTORM and STED.

 

Key features:

· Conjugated with Janelia Fluor® 549 (Ex: 552nm, Em: 579nm)

· Supplied as a more stable lyophilate

· Bright and photostable signal for repeated imaging

· Suited for IHC(IF), ICC, Western blotting and Flow cytometry

Description

Janelia Fluor® 549 conjugated streptavidin for detection and signal amplification of biotin coupled proteins and antibodies.

Write Your Own Review
You're reviewing:Streptavidin Janelia Fluor® 549
Rate this item:

Images

Figure 1: Parvalbumin positive interneuron cells in the rat hippocampus.

Rat hippocampus stained with HB6457 to detect Parvalbumin. Parvalbumin was detected using an anti-mouse biotin antibody (HB11345) followed by incubation with Streptavidin Janelia Fluor® 549 (HB18064).

Method: Rat brains were dissected and fixed overnight in 4% PFA before then being incubated in 30% sucrose (in PBS) until sunk (approx. 48hrs). A freezing microtome was used to cut 40µm horizontal slices before sections were incubated in 1% NaBH4 for 30 minutes. Sections were blocked in 0.05M glycine, 2% BSA and 3% donkey serum before incubation overnight in Parvalbumin HB6457 (1:1,000 dilution) at 4°C. This was followed by a two hour incubation with goat anti-mouse biotin antibody HB11345 at a dilution of 1:250 Following three washes in PBST, sections were incubated with Streptavidin Janelia Fluor® 549 (HB18064) at 1.0 µg/mL for 2 hours at room temperature. DAPI HB0747 was used at 1µg/ml to visualise cell nuclei. For more detail please see our  IHC(IF) protocol. Images were captured using a Leica DMI6000B inverted epifluorescence microscope. Images were captured using a 20x objective in a z-stack with exposures: DAP: 224.256 ms, Y3: 1044.272 ms. Stacks were deconvolved using Huygens professional then flattened using a maximum Z projection in ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676–682).

Figure 2. Parvalbumin positive interneurons and GFAP positive astrocytes in the rat hippocampus.

Rat hippocampus stained with HB6457 to detect Parvalbumin and HB6406 to detect GFAP. Parvalbumin was detected using an anti-mouse biotin antibody (HB11345) followed by incubation with Streptavidin Janelia Fluor® (HB18064).

Method: Rat brains were dissected and fixed overnight in 4% PFA before then being incubated in 30% sucrose (in PBS) until sunk (approx. 48hrs). A freezing microtome was used to cut 40µm horizontal slices before sections were incubated in 1% NaBH4 for 30 minutes. Sections were blocked in 0.05M glycine, 2% BSA and 3% donkey serum before incubation overnight in Parvalbumin HB6457 (1:1,000 dilution) and GFAP HB6406 (1:4000 dilution) at 4°C. This was followed by a two hour incubation with goat anti-mouse biotin antibody (HB11345) at a dilution of 1:250 and goat anti-chicken Alexa Fluor™ 488, (Invitrogen) at a dilution of 1:300. Following three washes in PBST, sections were incubated with Streptavidin Janelia Fluor® 549 (HB18064) at 1.0 µg/mL for 2 hours at room temperature. DAPI HB0747 IHC(IF) protocol. Images were captured using a Leica DMI6000B inverted epifluorescence microscope. Images were captured using a 20x objective in a z-stack with exposures: DAP: 224.256 ms, GFP: 677.506 ms, Y3: 1044.272 ms Stacks were deconvolved using Huygens professional then flattened using a maximum Z projection in ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676–682).

Figure 3. Parvalbumin positive interneuron populations in the rat hippocampus

Rat hippocampus stained with HB6457 to detect Parvalbumin. Parvalbumin was detected using anti-mouse biotin antibody HB11345 followed by incubation with Streptavidin Janelia Fluor® 549 (HB18064). Method: Rat brains were dissected and fixed overnight in 4% PFA before then being incubated in 30% sucrose (in PBS) until sunk (approx. 48hrs). A freezing microtome was used to cut 40µm horizontal slices before sections were incubated in 1% NaBH4 for 30 minutes. Sections were blocked in 0.05M glycine, 2% BSA and 3% donkey serum before incubation overnight in Parvalbumin HB6457 (1:1,000 dilution) at 4°C. This was followed by a two hour incubation with of goat anti-mouse biotin antibody HB11345 at a dilution of 1:250. Following three washes in PBST, sections were incubated with JF549 Streptavidin (HB18064) at 1.0 µg/mL for 2 hours at room temperature. DAPI HB0747 was used at 1µg/ml to visualise cell nuclei. For more detail please see our  IHC(IF) protocol. Images were captured using a Leica DMI6000B inverted epifluorescence microscope. Images were captured using a 20x objective in a z-stack with exposures: DAP: 224.256 ms, Y3: 1044.272 ms. Stacks were deconvolved using Huygens professional then flattened using a maximum Z projection in ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676–682).

Figure 4. Concentration response of Streptavidin Janelia Fluor® 549 (HB18064) staining in rat hippocampus.

Streptavidin Janelia Fluor® 549 (HB18064) produces optimal staining of parvalbumin positive interneurons in the hippocampus at 1.0 µg/mL.

Method: Rat brains were dissected and fixed overnight in 4% PFA before then being incubated in 30% sucrose (in PBS) until sunk (approx. 48hrs). A freezing microtome was used to cut 40µm horizontal slices before sections were incubated in 1% NaBH4 for 30 minutes. Sections were blocked in 0.05M glycine, 2% BSA and 3% donkey serum before incubation overnight in anti-Parvalbumin HB6457 (1:1,000 dilution) at 4°C. This was followed by a two hour incubation with secondary biotin antibody at a 1:300 dilution (goat anti-mouse biotin antibody HB11345. Following three washes in PBST, sections were incubated with Streptavidin Janelia Fluor® 549 (HB18064) at 0.5 µg/mL, 1.0 µg/mL or 10 µg/mL for 2 hours at room temperature. DAPI HB0747 was used at 1µg/ml to visualise cell nuclei. For more detail please see our IHC(IF) protocol . Images were captured using a Leica DMI6000B inverted epifluorescence microscope. Images were captured using a 20x objective in a z-stack with exposures:

0.5 µg/mL: DAP: 116.034 ms, Y3: 948.378 ms

1.0 µg/mL: DAP: 224.256 ms, Y3: 1044.272 ms

10.0 µg/mL: DAP: 139.756 ms, Y3: 233.469 ms

Stacks were deconvolved using Huygens professional then flattened using a maximum Z projection in ImageJ (Schindelin et al., 2012. Nat Methods, 9(7), 676–682).

Optical Data

Fluorescence spectra Fluorescence Spectra
Emission color Yellow
Max excitation wavelength 549nm
Max emission wavelength 571nm
Closest laser lines 561nm
Spectrally similar dyes DyLight 550, Alexa Fluor® 546, Alexa Fluor® 555, BDY TMR-X, Atto 550, Cyanine 3, CF 555, TAMRA
Quantum Yield (φ) 0.88
Extinction Coefficient (ε) 101,000 M-1cm-1
Correction Factor 280 0.169

Biological Data

Application notes

#Protocol 1: Detecting biotin-labelled antibodies in IHC

1. Incubate free floating rat brain sections (40µm) in sodium borohydride (NaBH4) for 15 minutes followed by 2 hours in blocking buffer (0.05M glycine, 2% BSA and 3% donkey serum).

2. Incubate sections with primary antibody in blocking buffer at 4°C overnight, as in our IHC protocol.

3. Wash sections three times in PBST for 5 minutes each.

4. Incubate sections with 2 µg/mL goat anti-mouse biotin antibody HB11345 or goat anti-rabbit antibody HB11036 diluted in blocking buffer for 2 hours at RT.

5. Wash sections three times in PBST for 5 minutes each.

6. Incubate sections with 1 µg/mL Streptavidin Janelia Fluor® 549 in blocking buffer for 2 hours.

7. Wash sections three time in PBST for 5 minutes each.

8. Incubate sections with 10 µg/mL DAPI for 10 minutes.

9. Wash sections in dH2O, mount on glass slides with mounting media and cover with coverslip.

10. Image the sections on a microscope using a 561nm laser or TRITC filter set to excite Streptavidin Janelia Fluor® 549.

Solubility & Handling

Storage instructions

-20°C then use reconstitution advice

Reconstitution advice We recommend reconstituting with either 1ml of:
  • dH2O and storing at 4°C
  • 50:50 ratio of dH2O to glycerol and storing at -20°C
  • dH2O then aliquot and store at -80°C
Take care when opening as the precipitate is extremely light and can easily be lost if disturbed. When reconstituting make sure that the streptavidin is thoroughly dissolved by pipetting up and down before giving the streptavidin a brief spin at <10,000g to make sure that all material is recovered and at the bottom of the tube.
Storage buffer

When reconstituted contains PBS with 0.05% sodium azide and 1% recombinant BSA.

Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Molecular Weight 52
Formulation Lyophilised. When reconstituted contains 0.05% sodium azide and 1% recombinant albumin
Licensing details

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus

References for Streptavidin Janelia Fluor® 549

References are publications that support the biological activity of the product
  • Recent advances in the engineering and application of streptavidin-like molecules.

    Le Q et al (2019) Applied microbiology and biotechnology 103 : 7355-7365
  • Streptavidin-biotin technology: improvements and innovations in chemical and biological applications.

    Dundas CM et al (2013) Applied microbiology and biotechnology 97 : 9343-53
  • Essentials of biorecognition: the (strept)avidin-biotin system as a model for protein-protein and protein-ligand interaction.

    Wilchek M et al (2006) Immunology letters 103 : 27-32

3 Item(s)